Liav Abraham is a Senior Analyst covering the specialty pharmaceuticals sector and Co-Head of Citi’s equity research US healthcare team. Prior to this, Liav was on Citi’s European Pharmaceuticals research team, where she covered the European large-cap and specialty pharma sectors. Liav has held various roles within the financial services industry for the past 14 years. Prior to joining Citi, she covered the European pharmaceuticals sector for Morgan Stanley. Her experience also includes investment banking and mezzanine investing. Liav holds an MBA degree from Columbia University.